BeStock  
Stocks › Biotechnology › HRMY

Harmony Biosciences HRMY

US equityMarket cap rank #2704Biotechnology
$32.59 −$0.39 (-1.18%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $32.59 0.00%
Open$32.68
Prev close$32.98
Day range$32.51 – $33.43
Volume582.6K
Market cap$1.91B
P/E (TTM)10.8
Dividend yield–

Earnings

Average move on report day±7.3%last 16 reports
Closed higher10 of 1663% of the time
Best reaction+19.4%
Worst reaction-11.1%

Stock move on the day after each report

-4.7%2023/Q4+5.7%2024/Q1+6.2%2024/Q2+16.1%2024/Q3+8.2%2024/Q4+7.0%2025/Q1-1.7%2025/Q2+4.7%2025/Q3+4.9%2025/Q4-4.1%2026/Q1+8.9%2026/Q2-7.0%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026Pre Market±15.1%-7.04%Within range
2026/Q24 Aug 2026Pre Market±16.8%+8.93%Within range
2026/Q17 May 2026Pre Market±14.0%-4.15%Within range
2025/Q424 Feb 2026Pre Market±14.0%+4.91%Within range
2025/Q34 Nov 2025Pre Market±11.0%+4.74%Within range
2025/Q25 Aug 2025Pre Market±18.0%-1.69%Within range
2025/Q16 May 2025Pre Market±13.5%+6.98%Within range
2024/Q425 Feb 2025Pre Market±13.5%+8.16%Within range
2024/Q329 Oct 2024Pre Market±16.7%+16.06%Within range
2024/Q26 Aug 2024Pre Market±23.3%+6.18%Within range
2024/Q130 Apr 2024Pre Market±13.5%+5.68%Within range
2023/Q422 Feb 2024Pre Market±17.4%-4.70%Within range
2023/Q331 Oct 2023Pre Market±14.7%+19.43%Bigger than priced
2023/Q21 Aug 2023Pre Market±18.0%-3.90%Within range
2023/Q12 May 2023Pre Market±15.0%+2.41%Within range
2022/Q421 Feb 2023Pre Market–-11.08%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$268.92M+12.3% YoY
Operating profit$54.20M-17.2% YoY
Net profit$48.20M-5.2% YoY
Diluted EPS$0.81-6.9% YoY
Free cash flow$76.69M-29.4% YoY
Operating cash flow$76.69M

Revenue, last 8 quarters

$201.3MDec '24$184.7MMar '25$200.5MJun '25$239.5MSep '25$243.8MDec '25$215.4MMar '26$261.3MJun '26$268.9MSep '26

Net profit, last 8 quarters

$49.5MDec '24$45.6MMar '25$39.8MJun '25$50.9MSep '25$22.5MDec '25$32.5MMar '26$75.4MJun '26$48.2MSep '26

Profitability & balance sheet

Gross margin74.0%
Operating margin22.2%
Net margin18.1%
Return on equity18.7%
Return on assets13.3%
Return on invested capital15.1%
Current ratio3.44
Liabilities / assets27.5%
Cash & investments$771.14M
Total debt$149.10M
Net cash (debt)$622.03M
Free cash flow / sales32.6%

Discussion

No comments yet — be the first to weigh in on HRMY.

Sign in to join the discussion.

Scroll to Top